Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies

author
created [InstanceEdit:9671355] Rothfels, Karen, 2019-12-19
dbId 9671348
displayName Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies
journal Br. J. Haematol.
pages 488-501
pubMedIdentifier 31309543
schemaClass LiteratureReference
title Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies
url http://www.ncbi.nlm.nih.gov/pubmed/31309543
volume 187
year 2019
Cite Us!